TLR4 and cancer: Conversely, in HPV-negative cases, TLR4 hyperactivation leads to the activation of inflammatory pathways related to increasing cell proliferation, apoptosis inhibition, lymphatic and vascular neo-angiogenesis, and metastasis, favoring a “deviated” cancer-related inflammatory microenvironment.